Aug 10 (Reuters) - Reliant Pharmaceuticals Inc. filed with U.S. regulators on Friday to raise up to $400 million in an initial public offering of common stock.
The Liberty Corner, New Jersey-based company told the U.S Securities and Exchange Commission in a preliminary prospectus that Goldman Sachs & Co., Merrill Lynch & Co., JPMorgan, Bank of America Securities and Lazard Capital Markets were underwriting the IPO.
The company has applied to list its common stock on the New York Stock Exchange under the symbol “RRX.”
The filing did not reveal how many shares the company planned to sell or their expected price. (Reporting by Shivani Singh in Bangalore)